Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK
Authors:
- Juliet WarnerJWJuliet Warner
- Martin KnappMKMartin Knapp
- Robert KerwinRKRobert Kerwin
Open Access
- 1 June 2003
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 182 (6) , 505-508
Abstract
Background: Schizophrenia is a major cause of suicide, and symptoms characteristic of treatment-resistant disease are strong risk factors. Clozapine reduces symptoms in 60% of such patients and significantly decreases the risk of suicide.Aims: To model the impact of increased clozapine prescribing on lives saved and resource utilisation.Method: A model was built to compare current levels of clozapine prescribing with a scenario in which all suitable patients with treatment-resistant schizophrenia received clozapine.Results: It was estimated that an average of 53 lives could be saved in the UK each year. If clozapine is cost-neutral, the cost per life-year saved is $.5108. If clozapine achieves a 10% reduction in annual support costs, the net saving is $8.7 million per annum. An average of 167 acute beds would be freed each year.Conclusions: The use of clozapine in treatment-resistant schizophrenia saves lives, frees resources and is cost-effective.Keywords
This publication has 15 references indexed in Scilit:
- Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON studyActa Psychiatrica Scandinavica, 2002
- Active monitoring of 12760 clozapine recipients in the UK and IrelandThe British Journal of Psychiatry, 1999
- Cost of Schizophrenia to UK SocietyPharmacoEconomics, 1999
- A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory SchizophreniaNew England Journal of Medicine, 1997
- Cost-effectiveness of clozapineThe British Journal of Psychiatry, 1997
- Treatment-Resistant Schizophrenia - The Role of ClozapineCurrent Medical Research and Opinion, 1997
- Cost effectiveness of clozapine in neuroleptic-resistant schizophreniaAmerican Journal of Psychiatry, 1993
- Assessment of Costs and Benefits of Drug Therapy for Treatment-Resistant Schizophrenia in the United KingdomThe British Journal of Psychiatry, 1993
- Attempted suicide and depression in schizophreniaActa Psychiatrica Scandinavica, 1992
- A Study of Suicide in Schizophrenic In-patientsThe British Journal of Psychiatry, 1992